CoChat
Cited by 45

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products

Lee, Brian, Jung, Sunghoon, Hashimura, Yas, Lee, Maximilian, Borys, Breanna S., Dang, Tiffany, Kallos, Michael S., Rodrigues, Carlos A. V., Silva, Teresa P., Cabral, Joaquim M. S. · 2022 · Bioengineering

Abstract

Allogeneic cell therapy products, such as therapeutic cells derived from pluripotent stem cells (PSCs), have amazing potential to treat a wide variety of diseases and vast numbers of patients globally. However, there are various challenges related to manufacturing PSCs in single-use bioreactors, particularly at larger volumetric scales. This manuscript addresses these challenges and presents potential solutions to alleviate the anticipated bottlenecks for commercial-scale manufacturing of high-quality therapeutic cells derived from PSCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/bioengineering9030092

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 34

  1. Takahashi, 2013, Induced Pluripotent Stem Cells in Medicine and Biology, Development, 140, 2457, 10.1242/dev.092551 · DOI · Paper page
  2. Simaria, 2014, Allogeneic Cell Therapy Bioprocess Economics and Optimization: Single-Use Cell Expansion Technologies, Biotechnol. Bioeng., 111, 69, 10.1002/bit.25008 · DOI · Paper page
  3. Rodrigues, 2011, Stem Cell Cultivation in Bioreactors, Biotechnol. Adv., 29, 815, 10.1016/j.biotechadv.2011.06.009 · DOI · Paper page
  4. Cabral, J.M.S., and Lobato da Silva, C. (2018). Bioreactors for Human Pluripotent Stem Cell Expansion and Differentiation. Bioreactors for Stem Cell Expansion and Differentiation, CRC Press. · DOI
  5. Chen, 2013, Application of Human Mesenchymal and Pluripotent Stem Cell Microcarrier Cultures in Cellular Therapy: Achievements and Future Direction, Biotechnol. Adv., 31, 1032, 10.1016/j.biotechadv.2013.03.006 · DOI · Paper page
  6. Panchalingam, 2021, Development of Bioreactor Protocols for Stem Cell-Based Therapies, Can. J. Chem. Eng., 99, 2505, 10.1002/cjce.24225 · DOI
  7. Stolberg, 2009, Can Shear Stress Direct Stem Cell Fate?, Biotechnol. Progr., 25, 10, 10.1002/btpr.124 · DOI · Paper page
  8. Kinney, 2011, The Multiparametric Effects of Hydrodynamic Environments on Stem Cell Culture, Tissue Eng. B Re., 17, 249, 10.1089/ten.teb.2011.0040 · DOI
  9. Baghbaderani, 2008, Expansion of Human Neural Precursor Cells in Large-Scale Bioreactors for the Treatment of Neurodegenerative Disorders, Biotechnol. Progr., 24, 859, 10.1021/bp070324s · DOI
  10. Youn, 2005, Large-Scale Expansion of Mammary Epithelial Stem Cells in Suspension Bioreactors, Biotechnol. Progr., 21, 984, 10.1021/bp050059f · doi:10.1021/bp050059f
  11. Lu, 2021, CAR-NK cells from engineered pluripotent stem cells: Off-the-shelf therapeutics for all patients, Stem Cells Transl. Med., 10, S10, 10.1002/sctm.21-0135 · DOI
  12. Nogueira, 2019, Strategies for The Expansion of Human Induced Pluripotent Stem cells as Aggregates in Single-Use Vertical-Wheel Bioreactors, J. Biol. Eng., 13, 1, 10.1186/s13036-019-0204-1 · DOI
  13. Bauwens, 2008, Control of Human Embryonic Stem Cell Colony and Aggregate Size Heterogeneity Influences Differentiation Trajectories, Stem Cells, 26, 2300, 10.1634/stemcells.2008-0183 · DOI · Paper page
  14. Xie, 2017, Controlled Self-Assembly of Stem Cell Aggregates Instructs Pluripotency and Lineage Bias, Sci. Rep., 7, 1, 10.1038/s41598-017-14325-9 · DOI
  15. Gates, 2012, Mass Transfer Limitations in Embryoid Bodies During Human Embryonic Stem Cell Differentiation, Cells Tissues Organs, 196, 34, 10.1159/000330691 · DOI
  16. Wu, J., Rostami, M.R., Cadavid Olaya, D.P., and Tzanakakis, E.S. (2014). Oxygen Transport and Stem Cell Aggregation in Stirred-Suspension Bioreactor Cultures. PLoS ONE, 9. · DOI
  17. Nogueira, 2020, Suspension Culture of Human Induced Pluripotent Stem Cells in Single-Use Vertical-Wheel Bioreactors Using Aggregate and Microcarrier Culture Systems, Methods Mol. Biol., 2286, 167, 10.1007/7651_2020_287 · DOI
  18. Kempf, 2016, Large-Scale Production of Human Pluripotent Stem Cell Derived Cardiomyocytes, Adv. Drug Deliv. Rev., 96, 18, 10.1016/j.addr.2015.11.016 · DOI · Paper page
  19. Borys, 2018, Scale-Up of Embryonic Stem Cell Aggregate Stirred Suspension Bioreactor Culture Enabled by Computational Fluid Dynamics Modeling, Biochem. Eng. J., 133, 157, 10.1016/j.bej.2018.02.005 · DOI
  20. Manstein, 2021, High Density Bioprocessing of Human Pluripotent Stem Cells by Metabolic Control and In Silico Modeling, Stem Cells Transl. Med., 10, 1063, 10.1002/sctm.20-0453 · DOI
  21. Borys, 2019, Using Computational Fluid Dynamics (CFD) Modeling to Understand Murine Embryonic Stem Cell Aggregate Size and Pluripotency Distributions in Stirred Suspension Bioreactors, J. Biotechnol., 304, 16, 10.1016/j.jbiotec.2019.08.002 · DOI
  22. Mollet, 2004, Bioprocess Equipment: Characterization of Energy Dissipation Rate and its Potential to Damage Cells, Biotechnol. Prog., 20, 1437, 10.1021/bp0498488 · DOI
  23. Minin, O. (2011). Chapter 4—CFD for Characterizing Standard and Single-Use Stirred Cell Culture Bioreactors. Computational Fluid Dynamics Technologies and Applications, IntechOpen. · doi:10.5772/686
  24. Cabral, J.M.S., Lobato da Silva, C., Chase, L.G., and Diogo, M.M. (2016). Chapter 5—Novel Single-Use Bioreactors for Scale-Up of Anchorage-Dependent Cell Manufacturing for Cell Therapies. Stem Cell Manufacturing, Elsevier, B.V.
  25. Borys, 2021, Overcoming Bioprocess Bottlenecks in the Large-Scale Expansion of High-Quality hiPSC Aggregates in Vertical-Wheel Stirred Suspension Bioreactors, Stem Cell Res. Ther., 12, 1, 10.1186/s13287-020-02109-4 · DOI
  26. Dang, 2021, Computational Fluid Dynamic Characterization of Vertical-Wheel Bioreactors Used for Effective Scale-Up of Human Induced Pluripotent Stem Cell Aggregate Culture, Can. J. Chem. Eng., 99, 2536, 10.1002/cjce.24253 · DOI
  27. Silva, 2020, Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by Immunostaining, JoVE, 160, 1
  28. Mas-Bargues, C., Sanz-Ros, J., Román-Domínguez, A., Inglés, M., Gimeno-Mallench, L., El Alami, M., Viña-Almunia, J., Gambini, J., Viña, J., and Borrás, C. (2019). Relevance of Oxygen Concentration in Stem Cell Culture for Regenerative Medicine. Int. J. Mol. Sci., 20. · DOI · Paper page
  29. Chen, 2009, A Reduced Oxygen Tension (5%) is Not Beneficial for Maintaining Human Embryonic Stem Cells in the Undifferentiated State with Short Splitting Intervals, Hum. Reprod., 24, 71, 10.1093/humrep/den345 · DOI
  30. Farzaneh, 2020, Dissolved Oxygen Concentration Regulates Human Hepatic Organoid Formation from Pluripotent Stem Cells in a Fully Controlled Bioreactor, Biotechnol. Bioeng., 117, 3739, 10.1002/bit.27521 · DOI
  31. Roberts, 2019, Improved Expansion of Equine Cord Blood Derived Mesenchymal Stromal Cells by Using Microcarriers in Stirred Suspension Bioreactors, J. Biol. Eng., 13, 1, 10.1186/s13036-019-0153-8 · DOI
  32. Cunha, 2017, Bioprocess Integration for Human Mesenchymal Stem Cells: From Up to Downstream Processing Scale-Up to Cell Proteome Characterization, J. Biotechnol., 248, 87, 10.1016/j.jbiotec.2017.01.014 · DOI
  33. Heathman, 2015, Expansion, Harvest and Cryopreservation of Human Mesenchymal Stem Cells in a Serum-Free Microcarrier Process, Biotech. Bioeng., 112, 1696, 10.1002/bit.25582 · DOI
  34. Borys, 2020, Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors, Stem Cells Transl. Med., 9, 1036, 10.1002/sctm.19-0406 · DOI · Paper page

Cited by

See all 45

Metadata

Authors
Lee, B., Jung, S., Hashimura, Y., Lee, M., Borys, B. S., Dang, T., Kallos, M. S., Rodrigues, C. A. V., Silva, T. P., & Cabral, J. M. S.
Venue
Bioengineering
Publisher
MDPI AG
Published
2022-02-25
Volume
9
Issue
3
Pages
92
ISSN
2306-5354
Cited by
45
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products. https://app.cochat.ai/papers/10.3390/bioengineering9030092
The paper
Lee, B., Jung, S., Hashimura, Y., Lee, M., Borys, B. S., Dang, T., Kallos, M. S., Rodrigues, C. A. V., Silva, T. P., & Cabral, J. M. S. (2022). Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products. Bioengineering. https://doi.org/10.3390/bioengineering9030092

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.